Compare JRSH & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JRSH | CING |
|---|---|---|
| Founded | 2016 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.1M | 40.5M |
| IPO Year | 2017 | N/A |
| Metric | JRSH | CING |
|---|---|---|
| Price | $3.20 | $6.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $4.00 | ★ $31.33 |
| AVG Volume (30 Days) | 70.3K | ★ 349.3K |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | ★ 6.27% | N/A |
| EPS Growth | ★ 56.25 | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $145,812,006.00 | N/A |
| Revenue This Year | $11.64 | N/A |
| Revenue Next Year | $10.06 | N/A |
| P/E Ratio | $21.33 | ★ N/A |
| Revenue Growth | ★ 24.43 | N/A |
| 52 Week Low | $2.81 | $3.20 |
| 52 Week High | $3.70 | $7.92 |
| Indicator | JRSH | CING |
|---|---|---|
| Relative Strength Index (RSI) | 48.32 | 58.40 |
| Support Level | $3.03 | $3.58 |
| Resistance Level | $3.52 | $6.85 |
| Average True Range (ATR) | 0.10 | 0.52 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 18.77 | 77.47 |
Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.